Skip to main content

A Phase 3 Study of Itacitinib or Placebo in Combination With Corticosteroids as Initial Treatment for Chronic Graft Versus Host Disease

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Incyte Corporation

Start Date

July 2, 2019

End Date

February 27, 2024
 

Administered By

Duke Cancer Institute

Awarded By

Incyte Corporation

Start Date

July 2, 2019

End Date

February 27, 2024